Annals of Clinical Neurophysiology

The Korean Society of Clinical Neurophysiology (대한임상신경생리학회)
권호 표지
DOI QR코드

DOI QR Code

Primary Aldosteronism Presenting as Hypokalemia and Rhabdomyolysis

저칼륨혈증과 횡문근융해증으로 발현한 원발성 알도스테론증 1예

  • Park, Kee Hong (Department of Neurology, Gyeongsang National University Hospital) ;
  • Kim, Soo-Kyung (Department of Neurology, Gyeongsang National University Hospital) ;
  • Cho, Eun Bin (Department of Neurology, Gyeongsang National University Changwon Hospital) ;
  • Jeong, Heejeong (Department of Neurology, Gyeongsang National University Changwon Hospital) ;
  • Choi, Nack-Cheon (Department of Neurology, Gyeongsang National University Hospital) ;
  • Kwon, Oh-Young (Department of Neurology, Gyeongsang National University Hospital) ;
  • Lim, Byeong Hoon (Department of Neurology, Gyeongsang National University Hospital) ;
  • Hahm, Jong Ryeal (Department of Neurology, Gyeongsang National University Hospital) ;
  • Park, Ki-Jong (Department of Neurology, Gyeongsang National University Changwon Hospital)
  • 박기홍 (경상대학교병원 신경과) ;
  • 김수경 (경상대학교병원 신경과) ;
  • 조은빈 (창원경상대학교병원 신경과) ;
  • 정희정 (창원경상대학교병원 신경과) ;
  • 최낙천 (경상대학교병원 신경과) ;
  • 권오영 (경상대학교병원 신경과) ;
  • 임병훈 (경상대학교병원 신경과) ;
  • 함종렬 (경상대학교병원 신경과) ;
  • 박기종 (창원경상대학교병원 신경과)
  • Received : 2016.02.24
  • Accepted : 2016.05.17
  • Published : 2016.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

Primary aldosteronism is one of the most common cause of secondary hypertension and can be accompanied with hypokalemia. Rhabdomyolysis with hypokalemia in primary aldosteronism has been rarely reported. We describe a patient of primary aldosteronism who presented with limb-girdle type weakness.

Keywords

References

  1. Funder JW, Carey RM, Fardella C, Gomez-Sanchez CE, Mantero F, Stowasser M, et al. Case detection, diagnosis, and treatment of patients with primary aldosteronism: An endocrine society clinical practice guideline. J Clin Endocrinol Metab 2008;93:3266-3281. https://doi.org/10.1210/jc.2008-0104
  2. Omura M, Sasano H, Saito J, Yamaguchi K, Kakuta Y, Nishikawa T. Clinical characteristics of aldosterone-producing microadenoma, macroadenoma, and idiopathic hyperaldosteronism in 93 patients with primary aldosteronism. Hypertens Res 2006;29:883-889. https://doi.org/10.1291/hypres.29.883
  3. Lee JH, Kim E, Chon S. Hypokalemia-induced rhabdomyolysis by primary aldosteronism coexistent with sporadic inclusion body myositis. Ann Rehabil Med 2015;39:826-832. https://doi.org/10.5535/arm.2015.39.5.826
  4. Park W, Kim DH, Han KC, Bae YH, Kim SH, Ju JH, et al. A case of primary aldosteronism with rhabdomyolysis. Korean J Nephrol 2005;24:845-850.
  5. Kim B, No HJ, Lim YH, Kim HJ, Kim HY, Park BH, et al. A case of primary aldosteronism accompanied by rhabdomyolysis. Korean J Med 2006;70:261-266.
  6. Kim HI, Baek SA, Hwang HS, Lee WH, Kang GW, Lee IH. A case of primary aldosteronism accompanied by hypokalemic rhabdomyolysis. Yeungnam Univ J Med 2012;29:113-117. https://doi.org/10.12701/yujm.2012.29.2.113
  7. Chao CT, Wu VC, Kuo CC, Lin YH, Chang CC, Chueh SJ, et al. Diagnosis and management of primary aldosteronism: an updated review. Ann Med 2013;45:375-383. https://doi.org/10.3109/07853890.2013.785234
  8. Zimmerman JL, Shen MC. Rhabdomyolysis. Chest 2013;144:1058-1065. https://doi.org/10.1378/chest.12-2016
  9. Ellison DH, Loffing J. Thiazide effects and adverse effects: Insights from molecular genetics. Hypertension 2009;54:196-202. https://doi.org/10.1161/HYPERTENSIONAHA.109.129171
  10. Furberg CD, Wright JT, Davis BR, Cutler JA, Alderman M, Black H, et al. The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic. J Am Med Assoc 2002;288:2981-2997. https://doi.org/10.1001/jama.288.23.2981